Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferon

Xia Wang(University of Leicester), Xiucheng Pan(Apple (Israel)), Juan Fu(Zhejiang International Studies University), Zhi‐Qiang Xu(Nanjing Medical University), Li Li(Gilead Sciences (United States)), Yan Li(Centers for Disease Control and Prevention)
Medicine
June 1, 2018
10.1097/md.0000000000010891
Cited by 3

Related Papers

Genome sequence and genetic diversity of the common carp, Cyprinus carpio
|Nature Genetics|2014|677
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
|New England Journal of Medicine|2016|437
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
|The Lancet|2023|385
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
|The Lancet|2019|271
Identification of a Novel Astrovirus (Astrovirus VA1) Associated with an Outbreak of Acute Gastroenteritis
|Journal of Virology|2009|222